BRCA1 and neoplasm: To ensure genetic counselling is delivered in a timely manner to avoid missed therapeutic and prevention opportunities, the authors of a Canadian review article on genetic assessments for BRCA-associated malignancies recommended a tumour-first testing model to detect both somatic and germline BRCA1/2 cases and to ensure that this is available to all patients without depending on a referral system [117].